Expression of TRPC1 and SBEM protein in breast cancer tissue and its relationship with clinicopathological features and prognosis of patients

Zhang,Yongqing; Lun,Xiaoqin; Guo,Weiling

doi:10.3892/ol.2020.12255

Expression of TRPC1 and SBEM protein in breast cancer tissue and its relationship with clinicopathological features and prognosis of patients

Authors:
- Yongqing Zhang
- Xiaoqin Lun
- Weiling Guo
View Affiliations

Affiliations: Department of General Surgery, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
Published online on: October 29, 2020 https://doi.org/10.3892/ol.2020.12255
Article Number: 392

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study investigated the relationship of the expression of transient receptor potential channel 1 (TRPC1), small breast epithelial mucin (SBEM) in breast cancer tissues with clinical pathological features and prognosis of patients. Altogether 50 patients with breast cancer who were treated in Weifang People's hospital from April 2017 to November 2018 were selected, and the mRNA and protein differences of TRPC1 and SBEM in breast cancer patients and normal breast cancer tissues were detected by qRT‑PCR and Western blot. Spearman test was used for correlation analysis. Logistic univariate and multivariate analysis were performed on the risk factors related to breast cancer metastasis in breast cancer patients. The expression of TRPC1 and SBEM in breast cancer tissues was significantly higher than that in normal breast tissues (P<0.001). The mRNA expression of TRPC1, SBEM and protein was not related to age, tumor size and tissue grade of breast cancer patients, but related to TNM stage, clinical stage and lymph node metastasis (P<0.001). The relative expression of TRPC1 was positively correlated with clinical stage of breast cancer (r=0.992, P<0.001). The relative expression of SBEM was positively correlated with the clinical stage of breast cancer (r=0.853, P<0.001). The relative expression of TRPC1 was positively correlated with TNM staging of breast cancer (r=0.860, P<0.001). The relative expression of SBEM was positively correlated with TNM staging of breast cancer (r=0.880, P<0.001). Multivariate conditional Logistic regression analysis showed that TNM staging, TRPC1, SBEM were independent risk factors for malignant breast cancer metastasis. On the contrary, expression of TRPC1 and SBEM in breast cancer tissues was up‑regulated. TRPC1 and SBEM may be involved in the process of breast cancer occurrence, development and metastasis, and can be used as potential tissue biomarkers in diagnosis of breast cancer metastasis and disease assessment.

View Figures

View References

1	Arun G and Spector DL: MALAT1 long non-coding RNA and breast cancer. RNA Biol. 16:860–863. 2019. View Article : Google Scholar : PubMed/NCBI
2	Kennedy SP, Han JZR, Portman N, Nobis M, Hastings JF, Murphy KJ, Latham SL, Cadell AL, Miladinovic D, Marriott GR, et al: Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer. Breast Cancer Res. 21:432019. View Article : Google Scholar : PubMed/NCBI
3	Ishay-Ronen D, Diepenbruck M, Kalathur RKR, Sugiyama N, Tiede S, Ivanek R, Bantug G, Morini MF, Wang J, Hess C and Christofori G: Gain fat-lose metastasis: Converting invasive breast cancer cells into adipocytes inhibits cancer metastasis. Cancer Cell. 35:17–32. e6. 2019. View Article : Google Scholar : PubMed/NCBI
4	Benjamin MA, Sinnott C, Bawa S, Kaufman DI, Guarino K and Addona T: Re-excision rate after partial mastectomy in oncoplastic breast-conserving surgery: A single-institutional experience and review of the literature. Ann Plast Surg. 82 (4S Suppl 3):S170–S172. 2019. View Article : Google Scholar : PubMed/NCBI
5	Kaczmarski K, Wang P, Gilmore R, Overton HN, Euhus DM, Jacobs LK, Habibi M, Camp M, Weiss MJ and Makary MA: Surgeon re-excision rates after breast-conserving surgery: A measure of low-value care. J Am Coll Surg. 228:504–512.e2. 2019. View Article : Google Scholar : PubMed/NCBI
6	Chen IX, Chauhan VP, Posada J, Ng MR, Wu MW, Adstamongkonkul P, Huang P, Lindeman N, Langer R and Jain RK: Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proc Natl Acad Sci USA. 116:4558–4566. 2019. View Article : Google Scholar : PubMed/NCBI
7	Baker E, Whiteoak N, Hall L, France J, Wilson D and Bhaskar P: Mammaglobin-A, VEGFR3, and Ki67 in human breast cancer pathology and five year survival. Breast Cancer (Auckl). 13:11782234198589572019.PubMed/NCBI
8	Malmgren J, Hurlbert M, Atwood M and Kaplan HG: Examination of a paradox: Recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011. Breast Cancer Res Treat. 174:505–514. 2019. View Article : Google Scholar : PubMed/NCBI
9	Esteva FJ, Hubbard-Lucey VM, Tang J and Pusztai L: Immunotherapy and targeted therapy combinations in metastatic breast cancer. Lancet Oncol. 20:e175–e186. 2019. View Article : Google Scholar : PubMed/NCBI
10	Maeda SS, Borba VZ, Camargo MB, Silva DM, Borges JL, Bandeira F and Lazaretti-Castro M; Brazilian Society of Endocrinology Metabology (SBEM), : Recommendations of the Brazilian society of endocrinology and metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D. Arq Bras Endocrinol Metabol. 58:411–433. 2014.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
11	Sambale M, Intemann J, Pap T and Sherwood J: A homeostatic role for transient receptor potential cation channel (TRPC1) in articular cartilage. Osteoarthriti Cartilage. 27:S1752019. View Article : Google Scholar
12	Selli C, Pearce DA, Sims AH and Tosun M: Differential expression of store-operated calcium- and proliferation-related genes in hepatocellular carcinoma cells following TRPC1 ion channel silencing. Mol Cell Biochem. 420:129–140. 2016. View Article : Google Scholar : PubMed/NCBI
13	Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, et al: Palbociclib and letrozole in advanced breast cancer. N Engl J Med. 375:1925–1936. 2016. View Article : Google Scholar : PubMed/NCBI
14	Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, et al: Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N Engl J Med. 372:724–734. 2015. View Article : Google Scholar : PubMed/NCBI
15	Wang D, Khosla A, Gargeya R, Irshad H and Beck A: Deep learning for identifying metastatic breast cancer. arXiv preprint arXiv: 1606.05718. 2016.
16	Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DWY, Marass F, Gale D, et al: Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun. 6:87602015. View Article : Google Scholar : PubMed/NCBI
17	Pavan S, Meyer-Schaller N, Diepenbruck M, Kalathur RKR, Saxena M and Christofori G: A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis. Oncogene. 37:4197–4213. 2018. View Article : Google Scholar : PubMed/NCBI
18	Grant CV, Carver CM, Hastings SD, Ramachandran K, Muniswamy M, Risinger AL, Beutler JA and Mooberry SL: Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype. Breast Cancer Res Treat. 177:345–355. 2019. View Article : Google Scholar : PubMed/NCBI
19	Xue D, Xia T, Wang J, Chong M, Wang S and Zhang C: Role of regulatory T cells and CD8⁺ T lymphocytes in the dissemination of circulating tumor cells in primary invasive breast cancer. Oncol Lett. 16:3045–3053. 2018.PubMed/NCBI
20	Johnston APR, Rae J, Ariotti N, Bailey B, Lilja A, Webb R, Ferguson C, Maher S, Davis TP, Webb RI, et al: Journey to the centre of the cell: Virtual reality immersion into scientific data. Traffic. 19:105–110. 2018. View Article : Google Scholar : PubMed/NCBI
21	O'Grady S and Morgan MP: Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis. Biochim Biophys Acta Rev Cancer. 1869:310–320. 2018. View Article : Google Scholar : PubMed/NCBI
22	Kaemmerer E, Turner D, Peters AA, Roberts-Thomson SJ and Monteith GR: An automated epifluorescence microscopy imaging assay for the identification of phospho-AKT level modulators in breast cancer cells. J Pharmacol Toxicol Methods. 92:13–19. 2018. View Article : Google Scholar : PubMed/NCBI
23	Abdoul-Azize S, Buquet C, Li H, Picquenot JM and Vannier JP: Integration of Ca²⁺ signaling regulates the breast tumor cell response to simvastatin and doxorubicin. Oncogene. 37:4979–4993. 2018. View Article : Google Scholar : PubMed/NCBI
24	Pu Q, Zhao Y, Sun Y, Huang T, Lin P, Zhou C, Qin S, Singh BB and Wu M: TRPC1 intensifies house dust mite-induced airway remodeling by facilitating epithelial-to-mesenchymal transition and STAT3/NF-κB signaling. FASEB J. 33:1074–1085. 2018. View Article : Google Scholar : PubMed/NCBI
25	Xu Z, Shao Z, Wang M, Thorndike EH, Song Y and Shang ZJ: Expression of transient receptor potential canonical 1 (TRPC1) in tongue squamous cell carcinoma and correlations with clinicopathological features and outcomes. Int J Clin Exp Pathol. 10:1477–1487. 2017.
26	Pu Q, Huang Y, Lu Y, Peng Y, Zhang J, Feng G, Wang C, Liu L and Dai Y: Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer. Thorac Cancer. 7:348–354. 2016. View Article : Google Scholar : PubMed/NCBI
27	Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V, et al: The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI